
David Taylor
David Taylor is emeritus professor of Pharmaceutical and Public Health Policy at UCL
- HSJ Partners
Valuing young lives
In a four-part series, Bluebirdbio is exploring how the NHS can embrace the power of gene therapy as a treatment for rare diseases in the UK, including some of the systemic changes that will be needed. In this third column, David Taylor, emeritus professor of Pharmaceutical and Public Health Policy ...